Carol Suh

Carol Suh

San Francisco Bay Area
  • ARCH Venture Partners Partner · current
  • Orbital Therapeutics Co-founder, Board Member 2022–2025 · past
  • HIBio Board Member 2021–2024 · past
  • Neumora Co-Founder and Chief Strategy Officer 2019–2026 · past
  • Magenta Therapeutics Business Development and Corporate Strategy Associate; Launch Fellow 2016–2017 · past
  • Trinity Partners Senior Associate Consultant 2015–2016 · past
  • GlaxoSmithKline R&D Strategy; Innovation Fellow 2014 · past

Education

  • Stanford University Graduate School of Business Master of Business Administration - MBA
  • Yale University Master of Philosophy (M.Phil.)
  • Harvard University Bachelor of Arts (B.A.)
  • Palos Verdes Peninsula High School

Online